Interleukin-13 Receptor alpha2 Subunit
"Interleukin-13 Receptor alpha2 Subunit" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An interleukin-13 receptor subunit that is closely-related to the INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT. The receptor is found as a monomeric protein and has been considered to be a decoy receptor for interleukin-13 due the fact that it lacks cytoplasmic signaling domains.
| Descriptor ID |
D053663
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.600.300
|
| Concept/Terms |
Interleukin-13 Receptor alpha2 Subunit- Interleukin-13 Receptor alpha2 Subunit
- Interleukin 13 Receptor alpha2 Subunit
- IL13Ralpha2
- Interleukin-13 Receptor alpha2
- Interleukin 13 Receptor alpha2
- Receptor alpha2, Interleukin-13
- Interleukin-13 Decoy Receptor
- Decoy Receptor, Interleukin-13
- Interleukin 13 Decoy Receptor
- Antigens, CD213a2
- Interleukin-13 Receptor alpha2 Chain
- Interleukin 13 Receptor alpha2 Chain
- CD213a2 Antigen
- Antigen, CD213a2
- CD213a2 Antigens
- IL-13 Receptor alpha2
- IL 13 Receptor alpha2
- Receptor alpha2, IL-13
- Receptor, Interleukin-13 alpha2
- Interleukin-13 alpha2 Receptor
- alpha2 Receptor, Interleukin-13
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-13 Receptor alpha2 Subunit".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-13 Receptor alpha2 Subunit".
This graph shows the total number of publications written about "Interleukin-13 Receptor alpha2 Subunit" by people in this website by year, and whether "Interleukin-13 Receptor alpha2 Subunit" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interleukin-13 Receptor alpha2 Subunit" by people in Profiles.
-
IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM. J Immunother Cancer. 2023 02; 11(2).
-
Interleukin-13 receptor subunit alpha-2 is a target of progesterone receptor and steroid receptor coactivator-1 in the mouse uterus?. Biol Reprod. 2020 10 05; 103(4):760-768.
-
Response to the comment on "Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma" by Bielamowicz et al. Neuro Oncol. 2018 06 18; 20(7):1004-1005.
-
Comment on "Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma". Neuro Oncol. 2018 06 18; 20(7):1003-1004.
-
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma. Neuro Oncol. 2018 03 27; 20(4):506-518.
-
Adoptive Transfer of IL13Ra2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma. Mol Ther. 2018 04 04; 26(4):986-995.
-
Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Ra2-CAR T Cells but Results in Antigen Loss Variants. Cancer Immunol Res. 2017 07; 5(7):571-581.
-
Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients. Gastroenterology. 2017 05; 152(6):1345-1357.e7.
-
Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape. J Clin Invest. 2016 08 01; 126(8):3036-52.
-
Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Ra2-positive Glioma. Mol Ther. 2016 Feb; 24(2):354-363.